Medwellai, Inc. (MWAI) Stock Price & Analysis
Medwellai, Inc. (MWAI) rose 0.00% to USD 0.37 as of September 8, 2026 at 22:28 UTC, according to Nexqual real-time market data.
MWAI last closed at USD 0.37; the session ranged USD 0.3–0.37 on volume of 650 shares. Market capitalization is —, with a 52-week range of USD 0.2–0.8 (OQB). Source: Nexqual, September 8, 2026 at 22:28 UTC.
Key Statistics (as of September 8, 2026 at 22:28 UTC)
| Price | USD 0.37 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.37 |
| Open | USD 0.3 |
| Day Range | USD 0.3 – 0.37 |
| 52-Week Range | USD 0.2 – 0.8 |
| Volume | 650 shares |
| Market Cap | — |
| Exchange | OQB |
Technical Analysis (MWAI)
Nexqual's technical model rates MWAI "BUY" based on 5 bullish and 1 bearish signals across 126 daily candles, as of September 8, 2026 at 22:28 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 58.5 (neutral) |
| vs SMA50 | Above (USD 0.33) |
| MACD | 0 (positive) |
Analyst Ratings (MWAI)
Wall Street analysts rate MWAI "None", per Nexqual as of September 8, 2026 at 22:28 UTC.
| Consensus Rating | None |
|---|
Earnings (MWAI)
Source: Nexqual, September 8, 2026 at 22:28 UTC.
Financials & Fundamentals (MWAI)
| Total Revenue | $1.86M |
|---|---|
| Revenue Growth (YoY) | +119.90% |
| Gross Margin | +31.25% |
| Operating Margin | -36.84% |
| Profit Margin | -123.84% |
| Current Ratio | 0.02 |
| Total Cash | $150,651 |
| Total Debt | $592,482 |
| Free Cash Flow | $4.25M |
Source: Nexqual, September 8, 2026 at 22:28 UTC.
Financial Health Score (MWAI)
Nexqual rates Medwellai, Inc.'s overall financial health "Mixed" across five dimensions, as of September 8, 2026 at 22:28 UTC.
| Growth | Strong — Revenue +120% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $151K cash, no debt |
| Cash Flow | Strong — FCF $4M, 228% margin |
| Efficiency | Mixed — No data |
Ownership (MWAI)
| Insider Ownership | +48.25% |
|---|---|
| Institutional Ownership | +0.00% |
| Float | 3.38M |
Source: Nexqual, September 8, 2026 at 22:28 UTC.
Leadership (MWAI)
Medwellai, Inc. is led by Stanislav Rubakh (age 64), President, CEO, CFO, Secretary, Treasurer & Director, per Nexqual as of September 8, 2026 at 22:28 UTC.
| President, CEO, CFO, Secretary, Treasurer & Director | Stanislav Rubakh (age 64) |
|---|
From Medwellai, Inc.'s Latest SEC 10-K Filing (filed 2025-09-30)
Key Strengths & Strategy (as disclosed to the SEC)
- MedWellAI Inc., through its subsidiary, develops, acquires, operates, and invests in businesses.
- It provides AI-driven healthcare and wellness solutions.
- The company also offers a B2B e-commerce platform for distributing pharmaceutical products, particularly GLP medications for weight loss and diabetes management.
- In addition, it provides an AI-powered ordering system with inventory tracking, smart suggestions, and support for healthcare providers such as wellness clinics, med spas, and corporate wellness facilities.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MGTI | MGT Capital Investments, Inc. | USD 0 | ▼ 15.79% |
| CCTL | Coin Citadel | USD 0 | ▲ 0% |
| BFCH | BitFrontier Capital Holdings, I | USD 0 | ▲ 0% |
| ASPT | ALADDIN SEPARATION TECHNOLOGIES | USD 0 | ▲ 0% |
| DMGGF | DMG Blockchain Solutions Inc. | USD 0.4 | ▲ 2.56% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 22:28 UTC. This page is informational and not investment advice.